Edition:
United States

Profile: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

537.15INR
15 Dec 2017
Change (% chg)

Rs3.20 (+0.60%)
Prev Close
Rs533.95
Open
Rs536.95
Day's High
Rs540.75
Day's Low
Rs534.20
Volume
672,761
Avg. Vol
952,523
52-wk High
Rs972.95
52-wk Low
Rs530.00

Glenmark Pharmaceuticals Limited is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW). It has approximately seven molecules, over two NCEs and approximately five NBEs in various stages of pre-clinical and clinical development. It is focused on developing and marketing branded and generic formulations. It focuses on manufacturing products across therapeutic areas of dermatology, respiratory and oncology. Its active pharmaceuticals ingredients (API) business spans over 80 countries, including regulated markets of the United States, Europe, Japan and Canada. Its products are primarily marketed in the United States and Western Europe. It has offices in over 40 countries, and operates approximately 20 manufacturing facilities in over five countries. It operates over five research and development (R&D) centers.

Company Address

Glenmark Pharmaceuticals Ltd

B D S Marg
Chakala, Off Western Express Hig
Andheri (E),
MUMBAI     400099
P: +9122.40189999
F: +9122.40189986

Company Web Links